Last deal

$70.7M
Local Amount - CNY 500.M

Amount

Series B

Stage

08.06.2020

Date

2

all rounds

$129.7M

Total amount

General

About Company
MabPlex provides contract development and manufacturing services for developing biopharmaceuticals.

Industry

Sector :

Subsector :

Keywords :

Also Known As

MabPlex

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

MabPlex offers global CRO/CMO services, specializing in the development and manufacturing of biopharmaceuticals. They provide contract services from DNA to finished biopharmaceutical goods, with a focus on high quality and effective solutions. MabPlex is one of the few providers for large scale ADC production worldwide and has experienced personnel with an average of 20 years of industry experience. They offer one-stop biologics manufacturing solutions globally, covering pre-clinical studies through commercial production. MabPlex also specializes in mammalian cell manufacturing and utilizes large single-use device bio-manufacturing processes.
Contacts

Social url